Held · Bookmarked
1 · 0
portfolio · users
Avg position size
0.5%
of holders' portfolios
13F filers
3
institutions
Market cap
$10.7B
52M shares
52-week range
$121.06 – $244.89
75% from low
Sector
HOSPITAL & MEDICAL SERVICE PLANS
Exchange
NYSE
CS
P/S (TTM)
0.2
EV / FCF (TTM)
36.7
Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.
www.molinahealthcare.com| Trader / Portfolio | Conviction |
|---|---|
| Robinhood Roth IraLiam | — |
| Institution | Shares | Reported |
|---|---|---|
| Scion Asset Managementas of 2025-09-30 | 125,000 | $23.9M |
| Renaissance Technologiesas of 2026-03-31 |
| Execution date | Ratio |
|---|---|
| 2011-05-23 | 3-for-2 |
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 16.6% | 66.8% | — | — | — | |
| Rev. Growth % | 11.7% | 18.5% | ||||
| Profit Margin % | 1.0% | 2.4% | 2.1% | |||
| Free Cash Flow Margin % | -1.4% | 2.8% | 3.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is +29.0% on the P/E track.
At today's price, your expected annual return is +36.3% on the P/E track.
At today's price, your expected annual return is +42.2% on the P/E track.
| 22,250 |
| $3.0M |
| Bridgewater Associatesas of 2026-03-31 | 2,087 | $278.2K |
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $44.5B | -0.9% | $5.23 | $5.14–$5.36 | 40.9× | 11 |
| 2027 | $48.2B | +8.3% | $9.72 | $8.96–$10.95 | 22.0× | 6 |
| 2028 | $51.1B | +6.1% | $13.55 | $11.08–$15.22 | 15.8× | 4 |
| 2029 | $56.2B | +10.0% | $21.41 | $19.91–$22.24 | 10.0× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-22 | $1.39 | $1.51 | +8.6% |
| 2026-04-22 | $1.90 | $2.35 | +23.7% |
| 2026-02-05 | $0.43 | $-2.75 | -739.5% |
| 2025-10-22 | $3.97 | $1.84 | -53.7% |
| 2025-07-23 | $5.62 | $5.48 | -2.5% |
| 2025-04-23 | $5.97 | $6.08 | +1.8% |
| 2025-02-05 | $5.74 | $5.05 | -12.0% |
| 2024-10-23 | $5.81 |
| $6.01 |
| +3.4% |
| $12.2B |
| — |
| GMEDGlobus Medical, Inc. | $75.77 | +2.13% | $10.2B | — |
| GRFSGrifols, S.A. | $7.48 | -0.93% | $6.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
DDI
DoubleDown Interactive Co., Ltd. American Depository Shares
1 co-holder · 100% overlap
BMBL
Bumble Inc. Class A Common Stock
1 co-holder · 100% overlap
GRSD
Grandstand Limited Ordinary Shares
1 co-holder · 100% overlap
GGR
Gogoro Inc. Ordinary Shares
1 co-holder · 100% overlap
LNSR
LENSAR, Inc. Common Stock
1 co-holder · 100% overlap
NNDM
Nano Dimension Ltd. American Depositary Shares
1 co-holder · 100% overlap
SIRI
Sirius XM Holdings, Inc
1 co-holder · 100% overlap
GSL
Global Ship Lease, Inc.
1 co-holder · 100% overlap
Ranked by collective conviction (sum of co-holders' % allocation) across public portfolios holding MOH.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$MOH Soon: medical cost ratio going down. The tenure curve, from the Counterpart whitepaper published December 2025, data as of September 30 2025: Year 1: 8 percent Year 2: 12 percent Year 3: 18 percent Year 4: 20 percent Clover Assistant is software that sits in front of the primary care doctor during the visit. It pulls claims, specialist charts, EHR data, pharmacy and lab results into one view of the member, then surfaces suspected diagnoses and open care gaps while the doctor is still in the room. Clover pays an enhanced rate for visits documented in it, which is why doctors actually use it. That enhanced rate is stated in the 10K. The mechanism is not complicated. Find the condition early, treat it early, and it does not turn into an admission two years later. Year one looks modest because that is the year you are finding things. By year three and four the cohort is managed and the curve bends.
View on StockTwits ↗
$MOH adding some. Looks great! Old resistance level about to become support
View on StockTwits ↗
Michael Burry Stays Bullish On VEEV, Calls SNOW 'Overvalued' — And Revisits 'Big Short' Thesis That Best Stocks Fall By Half First $VEEV $MOH $SNOW https://stocktwits.com/news/equity/markets/michael-burry-stays-bullish-on-veev-calls-snow-overvalued-and-revisits-big-short-thesis-that-best-stocks-fall-by-half-first/cZsMFjMRJHu
View on StockTwits ↗
$MOH Michael Blueberry has some longs actually. I like it too. His shorts are a little more controversial in my opinion.
View on StockTwits ↗$SYK $MOH bought some of each today. Need some strategic health stuff
View on StockTwits ↗
$MOH $SYK, When the AI play get scary- These two will hedge and grow!!
View on StockTwits ↗
$MOH Breaking: Michael Burry has disclosed his updated positions • Added to Lululemon $LULU longs at $115S • Added to Molina $MOH at $201 • Bought Sprouts Farmer’s Markets $SFM shares at $70S • Bought Temple & Webster $TPLWF shares in low $3S • Bought Build-a-Bear $BBW in mid-upper $30S • Trimmed PayPal $PYPL• 😳😳
View on StockTwits ↗
$MOH hopefully this rebounds hard like UNH did. We are still 50% off from the peaks a few years back!!!
View on StockTwits ↗
Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.